Sensor

The 90-Day Eversense Sensor is Changing Lives

The Eversense sensor sits just under the skin – providing 90 days of highly accurate CGM.1

Sensor Image
 

Actual Size:
3.5 MM x 18.3 MM

 
 

No More

Inconvenient or Painful Self-Insertions Every 14 Days

No More

wasted sensor when transmitter is removed

No More

Worrying About Losing a Sensor

No More

Overtaping required for adhesive to last for days

 

Having the sensor placed is straightforward and safe.

The tiny fluorescent sensor is placed just under the skin of your upper arm by a trained Health Care Provider. There’s a small incision which is then closed with Steri-StripsTM. Most people heal in a few days. And then you’re good to go for up to 3 months.

92% of patients reported no pain and discomfort when using the Sensor(1)

Features & Function

Icon Dots

Advanced fluorescence technology

Icon Calendar

Sensor lasts up to 90 days – eliminates frequent self-insertions

Icon On-Body

Only CGM providing on-body vibe alerts when glucose is low or high

Icon Accuracy

Very accurate over a 90-day period with MARD of 8.5%1

 

The sensor placement went very well. I felt nothing, no pain, no discomfort. There are no stitches, no sutures, just two steri strips and a bandage.

Robert, Eversense CGM User

Learn Why Robert Loves Eversense*

Watch Video

More about the sensor technology and how it works.

The Eversense sensor is encased in material which is compatible with the human body, or bio-compatible. It uses a patented fluorescent glucose-indicating polymer technology to measure glucose in the interstitial fluid (a thin layer of fluid that surrounds the body’s cells). The measurement is then relayed to the smart transmitter. Both the measurement and calculation of glucose values are done automatically every 5 minutes.

Sensor Video Thumbnail

Ready to be Unstoppable with Eversense?

To get started, fill out a simple form with a few details, and we'll contact you to begin your order.

get started

Madison, Eversense CGM user

Madison, Eversense CGM user

 
  1. Eversense CGM System Summary of Safety and Effectiveness Data (PMA P160048)
  2. Barnard KD, Kropff J, et al. Acceptability of Implantable Continuous Glucose Monitoring Sensor: Journal of Diabetes Science and Technology 2018, Vol. 12(3) 634 -638. DOI: 10.1177.
 

Disclaimer

The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For safety information click here.

Eversense, Eversense E3 Continuous Glucose Monitoring and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, and the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.

Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.